Brief: Oncopeptides Q1 Operating Profit SEK -59.835 Million
15/05/2025 07:00
May 15 (Reuters) - Oncopeptides Q1 sales SEK 13.267 million. Q1 adjusted free cash flow SEK -68.317 million Q1 adjusted EPS SEK -0.29 Q1 net income SEK -60.669 million
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy